Start-up pitch
The start-up pitch session is supported by INCATE. Ten finalists will be selected that have the opportunity to make a 5-minute-pitch of their venture in the start-up pitch session on 25 February 2025. The best pitch will win a 10,000 € prize from award sponsor Vossius, one of the leading IP law firms in Europe.
Proudly presenting the finalists
mycoBiologics Ltd
SoundCell
Inicure AB
DimiCare Biotech
DimiCare introduces a new generation of antibiotics: highly specific to pathogens, less prone to resistance, and effective against biofilm- and spore-producing bacteria.
Presented by: Juan A. Garcia-Sanchez
https://www.dimicare-biotech.com/
Precise Health SA
Precise Health SA leverages AI-powered platforms to match and engineer phages to bacteria in silico to accelerate treatment of time-sensitive and multidrug-resistant infections.
Presented by: José Bila
https://precisehealth.io/
Nostics
Nostics is developing a point-of-care diagnostic platform based on Surface Enhanced Raman Spectroscopy (SERS) and artificial intelligence (AI), to detect and identify pathogens at species-level in less than 10 minutes rather than days.
Presented by: Isabell Trinh
https://www.nostics.com
Elemental Therapeutics
We’re developing an oral therapeutic called PBT2, which can restore the efficacy of antibiotics against drug-resistant community-acquired bacterial pneumonia infections.
Presented by: Ella Casale
https://www.mcdevittlab.org
BioTryp Therapeutics
BioTryp is developing a novel anti-biofilm orally-administered treatment for bacterial infections (starting with urinary tract infections), as an add-on to antibiotics to increase their effectiveness and reduce treatment failure and recurrence.
Presented by: Ash Zarkan
https://biotryp.com/
Nanodecal
A rapid test for detecting Pseudomonas aeruginosa in sputum at the point of care.
Presented by: Roberto de la Rica
https://www.nanodecal.com/
Osta Therapeutics
Developing smart drugs to fight antibiotic resistance.
Presented by: Éric Samarut
https://www.ostatx.com